https://gbmsa.org.za/ 2026-05-12T08:21:43Z https://gbmsa.org.za/about-us/ 2025-04-30T12:05:43Z https://gbmsa.org.za/legislative-submissions/ 2024-11-12T15:05:13Z https://gbmsa.org.za/contact-us/ 2025-04-29T15:51:53Z https://gbmsa.org.za/video-post-youtube/ 2014-08-27T08:57:54Z https://gbmsa.org.za/video-post-vimeo/ 2014-08-27T09:17:18Z https://gbmsa.org.za/audio-post-soundcloud/ 2014-08-28T22:16:32Z https://gbmsa.org.za/post-with-the-featured-image-on-head-panel/ 2014-09-22T18:34:58Z https://gbmsa.org.za/post-with-classic-grid-collection-newsletter-form/ 2014-09-22T18:38:31Z https://gbmsa.org.za/post-with-slider/ 2014-09-24T10:29:21Z https://gbmsa.org.za/sudarshan-jain-takes-over-the-position-of-igba-chair/ 2021-01-13T15:56:44Z https://gbmsa.org.za/science-driven-evolution-for-sustainable-access-to-biologics/ 2021-05-12T09:53:18Z https://gbmsa.org.za/evaluation-registration-pathway-for-biosimilars/ 2021-08-27T13:11:36Z https://gbmsa.org.za/interchangeability-of-biosimilars/ 2021-08-27T13:32:51Z https://gbmsa.org.za/extrapolation-of-indications/ 2021-10-04T08:06:47Z https://gbmsa.org.za/todays-biosimilars-landscape-nov-1/ 2021-10-29T11:20:05Z https://gbmsa.org.za/the-biosimilars-road-ahead-nov-2/ 2021-10-29T11:22:49Z https://gbmsa.org.za/biosimilars-and-patient-benefits-nov-3/ 2021-10-29T11:24:29Z https://gbmsa.org.za/building-a-better-future-with-biosimilars-nov-4/ 2021-10-29T11:26:00Z https://gbmsa.org.za/join-the-biosimilars-movement-nov-5/ 2021-10-29T11:27:19Z https://gbmsa.org.za/selection-of-critical-quality-attributes-for-the-demonstration-of-biosimilarity/ 2021-11-02T05:40:27Z https://gbmsa.org.za/immunogenicity-considerations-for-evaluation-of-biosimilar-applications/ 2021-12-09T09:29:22Z https://gbmsa.org.za/generics-and-biosimilars-champion-cost-savers-in-the-healthcare-industry/ 2021-11-05T17:15:00Z https://gbmsa.org.za/novel-platforms-for-manufacturing-biosimilars-a-commentary/ 2022-01-17T10:03:30Z https://gbmsa.org.za/igba-establishes-a-ceo-advisory-committee/ 2022-01-15T16:20:00Z https://gbmsa.org.za/vivian-frittelli-takes-over-the-position-of-igba-chair/ 2022-02-10T16:28:25Z https://gbmsa.org.za/the-impact-of-patents-on-availability-and-patient-access-to-biosimilars/ 2022-02-22T08:25:51Z https://gbmsa.org.za/local-production-of-biosimilars-a-case-for-insulin/ 2022-04-10T16:14:05Z https://gbmsa.org.za/the-importance-of-reference-standards-in-biosimilar-development/ 2022-04-25T10:11:52Z https://gbmsa.org.za/igbas-newly-launched-ceo-advisory-committee-holds-inaugural-meeting-with-wto-director-general/ 2022-05-03T16:36:04Z https://gbmsa.org.za/south-africas-biosimilars-guideline-time-for-an-update/ 2022-05-31T01:32:42Z https://gbmsa.org.za/the-cost-of-stakeholder-trust-a-barrier-to-biosimilar-access/ 2022-07-19T05:11:50Z https://gbmsa.org.za/the-case-for-a-global-reference-product-for-biosimilar-development/ 2022-07-30T20:40:26Z https://gbmsa.org.za/the-biosimilars-guideline-opportunity-for-revision/ 2022-09-02T17:28:07Z https://gbmsa.org.za/generic-and-biosimilar-medicines-central-to-patient-health-and-global-healthcare-policies/ 2022-09-05T15:13:45Z https://gbmsa.org.za/gbw-video/ 2022-10-09T14:38:52Z https://gbmsa.org.za/non-biological-complex-drugs-time-for-a-special-guideline-for-the-registration-of-follow-on-versions-of-this-class-of-medicines/ 2022-11-08T03:31:53Z https://gbmsa.org.za/do-it-yourself-biomanufacturing-the-potential-consequence-of-regulations-and-market-forces-that-make-medicines-expensive/ 2022-12-07T23:06:31Z https://gbmsa.org.za/new-position-of-sahpra-on-interchangeability/ 2023-02-17T02:53:06Z https://gbmsa.org.za/sahpras-reliance-based-evaluation-pathway-for-rapid-review-and-registration-problems-and-opportunities/ 2023-03-01T15:21:06Z https://gbmsa.org.za/the-often-overlooked-constraint-to-local-biosimilar-industry-development-expert-human-resources/ 2023-03-27T19:25:55Z https://gbmsa.org.za/nitrosamine-impurities-are-they-a-major-concern-for-biologics/ 2023-05-04T23:34:37Z https://gbmsa.org.za/has-the-time-for-local-biosimilar-development-finally-arrived/ 2023-06-24T01:48:37Z https://gbmsa.org.za/advisory-committee/ 2023-06-30T05:10:23Z https://gbmsa.org.za/control-of-solid-state-characteristics-of-the-active-pharmaceutical-ingredients-polymorphism/ 2023-08-21T04:21:56Z https://gbmsa.org.za/control-of-solid-state-characteristics-of-the-active-pharmaceutical-ingredients-particle-size-distribution/ 2023-09-26T05:50:32Z https://gbmsa.org.za/setting-specifications-for-dissolution-of-immediate-release-solid-oral-dosage-forms-the-importance-of-the-biobatch/ 2023-11-08T02:14:13Z https://gbmsa.org.za/setting-specifications-for-dissolution-of-immediate-release-solid-oral-dosage-forms-the-importance-of-the-biobatch-2/ 2024-01-16T02:41:59Z https://gbmsa.org.za/the-interchangeability-and-substitutability-conundrum-time-for-convergence/ 2024-01-16T02:42:58Z https://gbmsa.org.za/generic-medicines/ 2025-04-29T11:51:09Z https://gbmsa.org.za/biosimilar-medicine/ 2024-11-13T09:03:17Z https://gbmsa.org.za/biosimilars-week/ 2024-11-13T08:37:32Z https://gbmsa.org.za/our-members/ 2024-11-12T09:55:11Z https://gbmsa.org.za/media-releases/ 2024-11-13T08:27:07Z https://gbmsa.org.za/the-gbm-blog/ 2026-07-16T09:12:51Z https://gbmsa.org.za/our-structure/ 2026-02-18T11:09:36Z https://gbmsa.org.za/policy-advocacy/ 2026-04-14T09:14:41Z https://gbmsa.org.za/igba-position-on-streamlined-development/ 2025-03-17T08:35:38Z https://gbmsa.org.za/in-support-of-global-comparator-for-biosimilars-waiving-bridging-studies-concerning-local-versus-global-reference-products/ 2025-03-17T08:43:50Z https://gbmsa.org.za/igba-releases-first-global-intellectual-property-and-competition-report/ 2025-04-10T07:30:41Z https://gbmsa.org.za/in-support-of-global-comparator-for-biosimilars-waiving-bridging-studies-concerning-local-versus-global-reference-products-2/ 2025-04-10T07:51:03Z https://gbmsa.org.za/igba-support-for-a-who-pandemic-agreement/ 2025-04-10T07:54:58Z https://gbmsa.org.za/igba-releases-first-global-intellectual-property-and-competition-report-2/ 2025-04-10T07:56:43Z https://gbmsa.org.za/reflection-paper-on-a-tailored-clinical-approach-in-4-biosimilar-development/ 2025-04-10T08:02:40Z https://gbmsa.org.za/igba-joins-ich-management-committee-and-welcomes-the-positive-vote-of-the-general-assembly/ 2025-04-10T08:08:45Z https://gbmsa.org.za/the-role-of-generic-and-biosimilar-medicines-in-reducing-healthcare-costs/ 2025-05-14T09:08:05Z https://gbmsa.org.za/regulatory-framework-for-generic-medicines-in-south-africa-challenges-and-the-road-ahead/ 2025-05-14T09:08:24Z https://gbmsa.org.za/addressing-medicine-accessibility-in-south-africa/ 2025-05-14T09:08:43Z https://gbmsa.org.za/medicine-pricing-in-south-africa-are-we-paying-too-much/ 2025-05-14T09:09:07Z https://gbmsa.org.za/igba-welcomes-ich-new-topic-for-harmonisation-framework-for-determining-utility-of-comparative-efficacy-studies-in-biosimilar-development-programs/ 2025-05-22T14:49:57Z https://gbmsa.org.za/new-areas-of-harmonisation-adopted-alongside-significant-advancement-of-ongoing-activities/ 2025-05-22T14:54:12Z https://gbmsa.org.za/bridging-the-gap-the-public-vs-private-sector-divide-in-south-africas-healthcare-system/ 2025-06-18T07:24:39Z https://gbmsa.org.za/regulatory-delays-and-market-entry-barriers-a-bottleneck-to-equitable-medicine-access-in-south-africa/ 2025-07-03T14:29:08Z https://gbmsa.org.za/pricing-pressures-and-affordability-challenges-balancing-access-and-sustainability-in-south-africas-medicine-market/ 2025-07-03T14:30:56Z https://gbmsa.org.za/supply-chain-disruptions-and-stockouts-addressing-a-persistent-threat-to-medicine-access/ 2025-07-03T14:32:45Z https://gbmsa.org.za/igba-welcomes-the-who-pandemic-agreement-and-calls-for-action-on-key-elements/ 2025-07-09T12:43:43Z https://gbmsa.org.za/policy-levers-that-matter-key-health-system-interventions-for-long-term-access/ 2025-08-20T11:38:15Z https://gbmsa.org.za/strengthening-local-pharmaceutical-manufacturing-and-supply-security/ 2025-09-02T08:30:31Z https://gbmsa.org.za/human-capital-and-governance-in-medicine-access/ 2025-10-01T10:18:45Z https://gbmsa.org.za/the-road-ahead-strategic-recommendations-for-equitable-access-to-medicines/ 2025-10-10T06:58:58Z https://gbmsa.org.za/breaking-down-the-basics-what-are-biosimilars-and-how-do-they-differ-from-generics/ 2025-11-21T07:44:21Z https://gbmsa.org.za/the-role-of-generic-and-biosimilar-medicines-in-managing-chronic-conditions-in-south-africa/ 2025-11-21T07:45:48Z https://gbmsa.org.za/navigating-regulatory-hurdles-how-sahpra-is-streamlining-approvals-for-generics-and-biosimilars/ 2025-11-21T08:19:46Z https://gbmsa.org.za/the-power-of-education-how-healthcare-providers-can-help-patients-understand-the-safety-and-efficacy-of-generics-and-biosimilars/ 2025-11-21T08:21:55Z https://gbmsa.org.za/bridging-innovation-and-access-rethinking-the-role-of-regulatory-systems-in-a-resilient-healthcare-future/ 2025-11-21T08:24:58Z https://gbmsa.org.za/the-economics-of-equitable-access/ 2025-12-10T13:10:13Z https://gbmsa.org.za/why-conversations-about-medicine-access-must-include-infrastructure-not-just-innovation/ 2025-12-10T13:11:12Z https://gbmsa.org.za/from-understanding-to-involvement-closing-the-trust-gap-in-community-health-research/ 2026-02-12T12:39:27Z https://gbmsa.org.za/regulatory-readiness-in-a-high-demand-environment-what-2026-signals-for-medicine-approvals-in-south-africa/ 2026-02-24T11:08:06Z https://gbmsa.org.za/supply-security-under-pressure-how-global-disruptions-are-reshaping-local-pharmaceutical-planning/ 2026-02-24T11:09:39Z https://gbmsa.org.za/regulatory-performance-and-backlog-status-in-2025-26-current-metrics-reliance-pathways-and-what-to-expect-next/ 2026-03-31T08:35:31Z https://gbmsa.org.za/tender-cycles-payment-timelines-and-supply-continuity-operational-realities-for-2026/ 2026-03-31T08:37:26Z https://gbmsa.org.za/digital-integration-across-the-medicine-value-chain-from-dossier-submission-to-stock-visibility/ 2026-04-16T08:16:32Z https://gbmsa.org.za/when-global-events-hit-local-shelves-understanding-how-conflict-and-disruption-affect-medicine-availability-in-south-africa/ 2026-04-22T09:10:23Z https://gbmsa.org.za/building-confidence-in-generics-and-biosimilars-the-role-of-patients-in-strengthening-sustainable-access/ 2026-05-05T08:13:53Z https://gbmsa.org.za/from-prescription-to-patient-understanding-the-journey-of-a-medicine-in-south-africa/ 2026-05-06T11:57:50Z https://gbmsa.org.za/cold-chain-and-critical-care-why-storage-and-transport-matter-more-than-we-think/ 2026-05-14T10:18:18Z https://gbmsa.org.za/trusted-through-standards-how-gbmsa-members-uphold-quality-safety-and-reliability-in-medicines/ 2026-05-27T10:42:14Z https://gbmsa.org.za/pharmacist-adoption-of-generics-and-biosimilars-supporting-access-and-confidence/ 2026-06-04T09:20:27Z https://gbmsa.org.za/winter-demands-and-generics-how-seasonal-illness-shapes-medicine-supply-and-substitution/ 2026-06-15T09:52:55Z https://gbmsa.org.za/pricing-value-and-volume-how-generics-and-biosimilars-sustain-access-in-a-constrained-healthcare-environment/ 2026-06-23T08:40:23Z https://gbmsa.org.za/molecule-to-market-how-innovation-translates-into-biosimilar-development/ 2026-07-01T07:40:55Z https://gbmsa.org.za/data-traceability-and-safety-how-medicines-are-tracked-across-their-lifecycle/ 2026-07-16T09:10:38Z https://gbmsa.org.za/how-generics-and-biosimilarssupport-long-term-treatment-sustainability/ 2026-07-23T06:59:29Z https://gbmsa.org.za/medicine-quality-beyond-approvalunderstanding-ongoing-monitoring-and-product-lifecycle-management/ 2026-07-29T08:25:11Z https://gbmsa.org.za/strengthening-medicine-security-the-role-of-supply-chain-diversification-in-a-changing-global-market/ 2026-08-06T07:45:41Z